Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Optagold
- Development stage
- Unknown
- Lead developer
- Ibn Sina Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Optagold is an oral antioxidant and micronutrient supplement formulated to support eye health and reduce the risk of progression of age-related eye diseases, such as age-related macular degeneration (AMD) and cataracts. It is a fixed-dose combination modeled on the AREDS2 (Age-Related Eye Disease Study 2) formulation, containing vitamin C, vitamin E, lutein, copper, and zinc. Vitamin C and vitamin E act as potent antioxidants that scavenge harmful free radicals in the lens and retina. Lutein, a carotenoid concentrated in the macula, helps protect the retinal tissue from oxidative and light-induced damage. Zinc serves as an essential cofactor for numerous ocular enzymes, while copper is included to prevent zinc-induced copper deficiency and associated anemia. Optagold is developed and marketed by Ibn Sina Pharmaceuticals in Bangladesh.
- Brand names
- Optagold
- Other names
- ascorbic acid + copper + lutein + vitamin e + zinccopper + lutein + vitamin c + vitamin e + zinc
Beyond the preview
Go deeper on Optagold.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Optagold.